[HTML][HTML] Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with …

CR Jutzeler, L Bourguignon, CV Weis, B Tong… - Travel medicine and …, 2020 - Elsevier
Introduction Since December 2019, a novel coronavirus (SARS-CoV-2) has triggered a
world-wide pandemic with an enormous medical and societal-economic toll. Thus, our aim was …

[HTML][HTML] International surveillance study in acute spinal cord injury confirms viability of multinational clinical trials

L Bourguignon, B Tong, F Geisler, M Schubert… - BMC medicine, 2022 - Springer
Background The epidemiological international landscape of traumatic spinal cord injury (SCI)
has evolved over the last decades along with given inherent differences in acute care and …

Serum albumin predicts long-term neurological outcomes after acute spinal cord injury

B Tong, CR Jutzeler, JJ Cragg… - … and Neural Repair, 2018 - journals.sagepub.com
Background. There is a need to identify reliable biomarkers of spinal cord injury recovery for
clinical practice and clinical trials. Objective. Our objective was to correlate serum albumin …

[HTML][HTML] A longitudinal study of the neurologic safety of acute baclofen use after spinal cord injury

JJ Cragg, B Tong, CR Jutzeler, FM Warner… - …, 2019 - Elsevier
The objective of our study was to determine whether treatment with baclofen is neurologically
safe with respect to exposure during recovery from spinal cord injury. We performed a …

The effect of non-gabapentinoid anticonvulsants on sensorimotor recovery after human spinal cord injury

FM Warner, CR Jutzeler, JJ Cragg, B Tong, L Grassner… - CNS drugs, 2019 - Springer
Background Recent observational studies have shown an association between gabapentinoid
anticonvulsants and greater motor recovery after spinal cord injury. There is preclinical …

Natural progression of routine laboratory markers after spinal trauma: a longitudinal, Multi-Cohort Study

L Bourguignon, AK Vo, B Tong, F Geisler… - Journal of …, 2021 - liebertpub.com
Our objective was to track and quantify the natural course of serological markers over the
1st year following spinal cord injury. For that purpose, data on serological markers, …

[HTML][HTML] Pharmacological management of acute spinal cord injury: A longitudinal multi-cohort observational study

CR Jutzeler, L Bourguignon, B Tong, E Ronca… - Scientific reports, 2023 - nature.com
Multiple types and classes of medications are administered in the acute management of
traumatic spinal cord injury. Prior clinical studies and evidence from animal models suggest that …

Perspectives on Data Sharing in Persons With Spinal Cord Injury

FM Warner, B Tong, J McDougall… - Neurotrauma …, 2023 - liebertpub.com
Open data sharing of clinical research aims to improve transparency and support novel scientific
discoveries. There are also risks, including participant identification and the potential for …

New life for an old idea: Assessing tonic heat pain by means of participant controlled temperature

CR Jutzeler, L Sirucek, PS Scheuren, T Bobo… - Journal of neuroscience …, 2019 - Elsevier
Bobo Tong contributed substantially to the data acquisition and revised the research
article for important intellectual content. Eitan Anenberg contributed substantially to the data …

Journal Club: Long-term functional outcome in patients with acquired infections after acute spinal cord injury

FM Warner, B Tong, CR Jutzeler, JJ Cragg… - Neurology, 2017 - AAN Enterprises
Infections, particularly pneumonia, are the primary cause of mortality in individuals with
spinal cord injury (SCI). Several factors may contribute to the high rate of infections in the SCI …